Search results
Results from the WOW.Com Content Network
On 25 March 2021, Bosnia and Herzegovina received 24,300 Pfizer–BioNTech and 26,400 Oxford–AstraZeneca COVID-19 vaccine units through COVAX, becoming the second European country to do so. [35] The country had already been, in total, donated over 20,000 doses of the Oxford–AstraZeneca vaccine by Serbia and Slovenia some weeks earlier.
By the end of April 2021, 3790 vaccine doses had been administered; 10,758 by the end of May; 46,760 by the end of June; 56,989 by the end of August; 108,602 by the end of September; 134,371 by the end of October; 236,710 by the end of November; 268,640 by the end of December 2021; 342,453 by the end of January 2022; 524,292 by the end of ...
COVAX-19 (or SpikoGen) is a recombinant protein-based COVID-19 vaccine developed by South Australian-based biotech company Vaxine, in collaboration with CinnaGen, a private company with operations in the Middle East.
Hulu + Live TV. Hulu + Live TV offers Hulu’s entire streaming library, which includes many current TV shows, plus more than 75 live channels. Specific channel selections vary by location and ...
WASHINGTON (Reuters) -Secretary of State Antony Blinken said on Wednesday the United States has brokered a deal between Johnson & Johnson and the COVAX vaccine-sharing program for the delivery of ...
The COVAX vaccine sharing platform designed to ensure equitable access to COVID-19 shots said on Thursday it aimed to deliver 1.8 billion doses to poorer countries in 2021 and hoped to fulfil ...
On 24 February 2021, a shipment of 600,000 Oxford–AstraZeneca COVID-19 vaccine to Accra via COVAX made it the first country in Africa to receive vaccines via the initiative. [5] The vaccination campaign began on 1 March 2021 as president Akufo-Addo received the first jab.
Sanofi (SNYNF) and GlaxoSmithKline (GSK) intend to make available 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine, if approved by regulatory authorities, to the ...